Variant/Haplotypes	Drug(s)	Phenotype Category	Significance	Sentence	Allele Of Frequency In Cases	Allele Of Frequency In Controls	Ratio Stat Type	Effect
rs3792269	metformin	Efficacy	yes	Allele G is associated with decreased response to metformin in people with Diabetes Mellitus as compared to allele A.	G	A	OR	0.27
rs1803274	rivastigmine	Efficacy	yes	Genotypes CT + TT is associated with decreased response to rivastigmine in people with Alzheimer Disease as compared to genotype CC.	C	T	OR	2.857
rs2241766	pioglitazone	Efficacy	yes	Genotype GT is associated with increased response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	G	T	OR	11.483
rs2241767	pioglitazone	Efficacy	no	Genotype AA are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes AG + GG.	G	A	OR	1.201
rs3821799	pioglitazone	Efficacy	no	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	C	T	OR	1.131
rs3774261	pioglitazone	Efficacy	no	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	OR	1.209
rs1063537	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	0.336
rs2082940	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	1.303
rs1063538	pioglitazone	Efficacy	no	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	C	T	OR	1.255
rs2305948	sunitinib	Efficacy	no	Genotype CT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotype CC.	T	C	OR	0.5
rs2231142	sunitinib	Efficacy	no	Genotype TT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes GG + GT.	T	G	OR	0.8
rs2231142	allopurinol	Efficacy	yes	Genotypes GT + TT are associated with decreased response to allopurinol in people with Gout as compared to genotype GG.	G	T	OR	0.36
rs10011796	allopurinol	Efficacy	no	Genotypes CT + TT are not associated with response to allopurinol in people with Gout as compared to genotype CC.	C	T	OR	0.85
rs249429	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	1.471
rs6923761	liraglutide	Efficacy	no	Genotypes AA + AG are associated with increased response to liraglutide in women with Obesity and Polycystic Ovary Syndrome as compared to genotype GG.	A	G	OR	3.06
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.49
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.72
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	1.78
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	0.76
rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	T	HR	1.754
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs3211371	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele C.	C	T	OR	1.408
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs3792269	metformin	Efficacy	yes	Allele G is associated with decreased response to metformin in people with Diabetes Mellitus as compared to allele A.	G	A	OR	0.27
rs1803274	rivastigmine	Efficacy	yes	Genotypes CT + TT is associated with decreased response to rivastigmine in people with Alzheimer Disease as compared to genotype CC.	C	T	OR	2.857
rs2241766	pioglitazone	Efficacy	yes	Genotype GT is associated with increased response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	G	T	OR	11.483
rs2241767	pioglitazone	Efficacy	no	Genotype AA are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes AG + GG.	G	A	OR	1.201
rs3821799	pioglitazone	Efficacy	no	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	C	T	OR	1.131
rs3774261	pioglitazone	Efficacy	no	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	OR	1.209
rs1063537	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	0.336
rs2082940	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	1.303
rs1063538	pioglitazone	Efficacy	no	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	C	T	OR	1.255
rs2305948	sunitinib	Efficacy	no	Genotype CT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotype CC.	T	C	OR	0.5
rs2231142	sunitinib	Efficacy	no	Genotype TT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes GG + GT.	T	G	OR	0.8
rs2231142	allopurinol	Efficacy	yes	Genotypes GT + TT are associated with decreased response to allopurinol in people with Gout as compared to genotype GG.	G	T	OR	0.36
rs10011796	allopurinol	Efficacy	no	Genotypes CT + TT are not associated with response to allopurinol in people with Gout as compared to genotype CC.	C	T	OR	0.85
rs249429	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	1.471
rs6923761	liraglutide	Efficacy	no	Genotypes AA + AG are associated with increased response to liraglutide in women with Obesity and Polycystic Ovary Syndrome as compared to genotype GG.	A	G	OR	3.06
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.49
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.72
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	1.78
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	0.76
rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	T	HR	1.754
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs3211371	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele C.	C	T	OR	1.408
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs249429	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	1.471
rs6923761	liraglutide	Efficacy	no	Genotypes AA + AG are associated with increased response to liraglutide in women with Obesity and Polycystic Ovary Syndrome as compared to genotype GG.	A	G	OR	3.06
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.49
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.72
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	1.78
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	0.76
rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	T	HR	1.754
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs3211371	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele C.	C	T	OR	1.408
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.49
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.72
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	1.78
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	0.76
rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	T	HR	1.754
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs3211371	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele C.	C	T	OR	1.408
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.49
rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	HR	0.72
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	1.78
rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	HR	0.76
rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	T	HR	1.754
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs3211371	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele C.	C	T	OR	1.408
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs3211371	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele C.	C	T	OR	1.408
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs3211371	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele C.	C	T	OR	1.408
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
